The role of environmental factors in insulin-dependent diabetes mellitus: An unresolved issue

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 5, 1999, Pages 777-781

  Kraine, Meredith R ^a   Tisch, Roland M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Diet; Drugs; Environmental factors; Infectious agents; Insulin dependent diabetes mellitus

Indexed keywords

ALLOXAN; ALPHA INTERFERON; ASPARAGINASE; CASEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ENVIRONMENTAL CHEMICAL; GLUTEN; IMMUNOSUPPRESSIVE AGENT; INSULIN; ISOTRETINOIN; MILK PROTEIN; NITROSO DERIVATIVE; PENTAMIDINE; RODENTICIDE; SOYBEAN PROTEIN; STREPTOZOCIN; SUPERANTIGEN; TACROLIMUS; VACOR;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CELL DAMAGE; CONFERENCE PAPER; DIABETOGENESIS; DIET; ENVIRONMENTAL FACTOR; EXPERIMENTAL DIABETES MELLITUS; HEREDITY; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MIMICRY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); GLYCINE MAX;

EID: 0032701015     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s5777     Document Type: Conference Paper

References (51)

1. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengard J, Kesaniemi YA. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060-1067 (1992).
2. Patrick SL, Moy CS, Laporte RE. The world of insulin-dependent diabetes mellitus: what international epidemiologic studies reveal about the etiology and natural history of IDDM. Diabetes Metab Rev 5:571-578 (1989).
3. Diabetes Epidemiology Research International Group. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 37:1113-1119 (1988).
4. Songini M, Muntoni S. High incidence of type-I diabetes in Sardinia [Letter]. Lancet 337:1047 (1991).
5. Singh B, Prange S, Jevnikar AM. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. Sem Immunol 10:79-86 (1998).
6. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 50:819-820 (1987).
7. Karounos DG, Wolinsky JS, Thomas JW. Monoclonal antibody to rubella virus capsid protein recognizes a β-cell antigen. J Immunol 150:3080-3085 (1993).
8. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxytase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 94:2125-2129 (1994).
9. Schloot NC, Roep BO, Wegmann DR, Yu L, Wang TB, Eisenbarth GS. T-cell reactivity to GAD65 peptide sequences, shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Diabetologia 40:332-338 (1997).
10. Benoist C, Mathis D. The pathogen connection. Nature 394:227-228 (1998).
11. Luppi P, Trucco M. Superantigens in insulin-dependent diabetes mellitus. Springer Semin Immunopathol 17:333-362 (1996).
12. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173 (1989).
13. Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1190 (1995).
14. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415-417 (1976).
15. Welsh N, Paabo S, Welsh M. Decreased mitochondrial gene expression in isolated islets of rats injected neonatally with streptozotocin. Diabetologia 34:626-631 (1991).
16. Malaisse WJ. Alloxan toxicity to the pancreatic β-cell. Biochem Pharmacol 31(22):3527-3534 (1982).
17. Harada M, Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27:604-606 (1984).
18. Yasunami R, Bach J-F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18:481-484 (1988).
19. Rothe H, Faust A, Schade U, Kleeman R, Bosse G, Hibino T, Martin S, Kolb H. Cyclophosphamide treatment of female nonobese diabetic mice causes enhanced expression of inducible nitric synthase and interferon-γ, but not of interleukin-4. Diabetologia 37:1154-1158 (1994).
20. Karam JH, Lewitt PA, Toung CW, Nowlain RE, Frankel BJ, Fujiya H, Freedman ZR, Grodsky GM. Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes 31:40-45 (1980).
21. Esposti MD, Ngo A, Myers MA. Inhibition of mitochondrial complex I may account for IDDM induced by intoxication with the rodenticide Vacor. Diabetes 45:1531-1534 (1996).
22. Wagner K, Webber SA, Kurland G, Boyle GJ, Miller SA, Cipriani L, Griffith BP, Fricker FJ. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. J Heart Lung Transplant 16:275-262 (1996).
23. Alessiani M, Cillo U, Fung JJ, Irish W, Abu-Elmagd K, Jain A, Takaya S, Van Thiel S, Starzl TE. Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 25:628-634 (1993).
24. Moxey-Mims M, Kay C, Light JA, Kher KK. Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506). Transplantation 65(5):617-619 (1998).
25. Fung J, Alessiani M, Abu-Elmagc K, Todo S, Shapiro R, Tzakis A, Van Thiel D, Armitage J, Jain A, McCauley J, et al. Adverse effects associated with the use of FK506. Transplant Proc 23:3105-3108 (1991).
26. Carroll PB, Rilo H, Reyes J, Alejandro R, Zeng Y, Ricordi C, Tzakis A, Shapiro R, Starzl TE. FK506 associated diabetes mellitus in the pediatric transplant population is a rare complication. Transplant Proc 23:3171-3172 (1991).
27. Perlman K, Ehrlich RM. Steroid diabetes in childhood. Am J Dis Child 136:54-68 (1982).
28. Owen OE, Cahill GF. Metabolic effects of exogenous glucocorticoids in fasted man. J Clin Invest 52:2596-2605 (1973).
29. Herold KC, Nagamatsu S, Buse JB, Kulsakdinun P, Steiner DF. Inhibition of glucose-stimulated insulin release from TC3 cells and rodent islets by an analog of FK 506. Transplantation 55:186-192 (1993).
30. Yale JF, Chamelian M, Courchesne S, Vigeant C. Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment. Transplant Proc 20(suppl 3):985-988 (1988).
31. Gailani S, Nussbaum A, Onuma T, Freeman A. Diabetes in patients treated with asparaginase. Clin Pharmacol Ther 12:487-490 (1971).
32. Land VJ, Sutow WW, Fernbach DJ, Lane DM, Williams TE. Toxicity of L-asparaginase in children with advanced leukemia. Cancer 30:339-347 (1972).
33. Waguri M, Hanafusa T, Itoh N, Imagawa A, Miyagawa J, Kawata S, Kono N, Kuwajima M, Matsuzawa Y. Occurrence of IDDM during interferon therapy for chronic viral hepatitis. Diabetes Res Clin Prac 23:33-36 (1994).
34. Bouchard PH, Sal P, Reach G, Caubarrere I, Ganeval D, Assan R. Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 31:40-45 (1982).
35. Timperley AC, Withnall RD, Rainford DJ. The development of insulin-dependent diabetes mellitus in renal transplant patient receiving oral isotretinoin [Letter]. Nephrol Dialysis Transplant 11:753 (1996).
36. Akerblom HK, Knip M. Putative environmental factors in type I diabetes. Diabetes Metab Rev 14:31-67 (1998).
37. Scott FW. Food-induced type-l diabetes in the BB rat. Diabetes Metab Rev 12:341-359 (1996).
38. See DM, Tilles JG. Pathogenesis of virus-induced diabetes in mice. J Infect Dis 171:1131-1138 (1995).
39. Yoon J-W, Onodera T, Notkins AL. Virus-induced diabetes mellitus - β cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med 148:1068-1080 (1978).
40. Notkins AL, Virus-induced diabetes mellitus - brief review. Arch Virol 54:1-17 (1977).
41. von Herrath MG, Holz A, Homann D, Oldstone MBA. Role of viruses in type I diabetes. Sem Immunol 10:87-100 (1998).
42. Shehadeh NN, La Rosa F, Lafferfty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmunity 6:291-296 (1991).
43. Flabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 154:4874-4882 (1995).
44. Qin H-Y, Elliot J-F, Rajotte RV, Singh B. Endogenous immune responses to glutamic acid decarboxylase (GAD67) in NOD mice are modulated by adjuvant immunotherapy [Abstract]. Autoimmunity 24(suppl 1):A133 (1996).
45. Qin H-Y, Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J Autoimmunity 10:271-278 (1997).
46. Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1:57-60 (1978).
47. Hyoty H, Hiltunen M., Lonnrot M. Enterovims infections and insulin-dependent diabetes mellitus - evidence for causality. Clin Diag Virol 9:77-84 (1998).
48. Hyoty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T et al. Childhood Diabetes in Finland (DiMe) Study Group. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44:652-657 (1995).
49. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4(7):781-785 (1998).
50. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Finegold D, Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355 (1994).
51. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 90:303-313 (1997).